S-3 GROUP

Lobbying for GOODRX · Healthcare company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income · posted Apr 17, 2026

Lobbying activity 2

Pharmacy

Issues regarding lower prescription drug prices for patients

Health Issues

Issues regarding lower prescription drug prices for patients

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.